Withdrawing Treatment and Deprescribing
X
GO

Withdrawing Treatment and Deprescribing

What we know

Deprescribing is the process of identifying and discontinuing treatments so that the benefits of treatments outweigh any adverse effects. These decisions are made in the context of an individual’s goals of care, level of functioning, life expectancy, values, and preferences. Sensitive discussion should precede any deprescribing as the discontinuation of a long-standing medication may cause distress to both the person and close relatives.

What can I do?

  • Align treatment with the person’s goals and wishes, which may change over time.
  • Ensure that medications (and other treatments) used to manage comorbidities continue to provide benefit to the patient as their illness progresses, while minimising any burdens or harms.
  • Discuss withdrawal of treatments and deprescribing of medications in the context of the wishes laid out in a person’s advance care directive.
  • Build a relationship with the person and his or her family/carer prior to discussing the withdrawal of treatment or the discontinuing of medications. This requires sensitivity to the person’s physical needs, values and goals as well as consideration of the impact on family/carers.
  • Explain the process of withdrawal and any potential issues from the withdrawal empathetically to the person and their family/carer - withdrawing treatment does not mean withdrawing care. Reassure the person and family that all measures to provide comfort and support will be continued. This includes attention to personal care, especially oral care and symptom relief. You can use these useful phrases (110kb pdf) where applicable.
  • Consider if other medicines are required to ensure comfort throughout the withdrawal period.
  • Pharmacists may be involved with palliative care in both hospital and community settings. If relevant, ask a pharmacist to conduct a Home Medicines Review (HMR) or a Residential Medication Management Review (RMMR)

 

What can I learn?

STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy) Lavan AH, Gallagher P, Parsons C, O’Mahony D.  Age and ageing. 2017 Jan 23.

STOPP/START = Screening Tool of Older Persons Prescriptions/Screening Tool to Alert doctors to Right Treatment

Communicating about end of life issues can be difficult; check out these resources::

Check out Deprescribing resources, Guides to the use of medicines in older people  and Rethinking Your Medications resources for consumers from phn Tasmania

Read: Hilmer SN, Gnjidic D. Prescribing for frail older people. Aust Prescr. 2017 Oct;40(5):174-178.

Pharmacovigilance in palliative care – a CPD activity for pharmacists

Managing your medicines from NPS Medicinewise

Therapeutic Guidelines (Palliative Care) (subscription needed)

 

What can my organisation do?

On admission to residential care or community service, give all clients the opportunity to discuss their wishes and treatment options at end-of-life. Ensure that these wishes are reviewed concurrently with a change in the care plan or with a change in the care needs.

Ensure that all new palliative clients are given the opportunity to discuss their wishes, and preferences for treatment options at end of life.

Include palliative care education in the staff development plan and ensure that all new staff are supported to be comfortable discussing end-of-life care with clients and their families.

Consider guidelines for withdrawal of medications that are no longer supporting quality of life.  Educate staff about the importance of the guidelines especially that each person is an individual with their own needs, beliefs, values that may be different to each staff and understanding and respect of each person’s individual decisions is most important.

Develop deprescribing policies for end-of-life to support General Practitioners and specialists as well as assuring individuals and their families that their comfort and symptom issues will be cared for.
 
Page updated 24 January 2019